Computer-aided drug design and pharmacophore modelling towards the discovery of novel anti-ebola agents

Authors

  • Kalliopi Io Diakou Laboratory of Genetics, Department of Biotechnology, School of Applied Biology & Biotechnology, Agricultural University of Athens, Athens, Greece
  • George P Chrousos 1st Department of Pediatrics, “Agia Sophia” Children’s Hospital
  • Elias Eliopoulos Laboratory of Genetics, Department of Biotechnology, School of Applied Biology & Biotechnology, Agricultural University of Athens, Athens, Greece
  • Dimitrios Vlachakis Laboratory of Genetics, Department of Biotechnology, School of Applied Biology & Biotechnology, Agricultural University of Athens, Athens, Greece

DOI:

https://doi.org/10.14806/ej.26.A.961

Keywords:

Drug Design, virus, Ebola,
EJ 26.A

Downloads

Published

2021-07-08

Issue

Vol. 26: Supplement A

Section

Oral Presentations

License

Authors who publish with this journal agree to the following terms:
  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).